Article
Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
Trends in cardiovascular medicine - 1 Jan 2008
Lebrin Franck, Mummery Christine L
Abstract excerpt
Endoglin is emerging as a pivotal component of the gateway for signaling by transforming growth factor-beta (TGF-beta) in vascular endothelial cells. Mutations in endoglin cause a rare vascular disorder in humans known as hereditary hemorrhagic telengiectasia (HHT). Although rare, in-depth analysis of mutant mice and mononuclear cells from the blood of patients with HHT have provided novel and exciting insights...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
